참고문헌
- Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010;20:202-213. https://doi.org/10.1002/rmv.655
- Rowshani AT, Bemelman FJ, van Leeuwen EM, van Lier RA, ten Berge IJ. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation 2005;79:381-386. https://doi.org/10.1097/01.TP.0000148239.00384.F0
- Powell RD, Warner NE, Levine RS, Kirsner JB. Cytomegalic inclusion disease and ulcerative colitis: report of a case in a young adult. Am J Med 1961;30:334-340. https://doi.org/10.1016/0002-9343(61)90105-X
- Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004;53(Pt 11):1155-1160. https://doi.org/10.1099/jmm.0.45629-0
- Wada Y, Matsui T, Matake H, et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum 2003;46(10 Suppl):S59-S65. https://doi.org/10.1007/s10350-004-6497-1
- Domenech E, Vega R, Ojanguren I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008;14:1373-1379. https://doi.org/10.1002/ibd.20498
- Maconi G, Colombo E, Zerbi P, et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 2005;37:418-423. https://doi.org/10.1016/j.dld.2005.01.011
- Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001;96:773-775. https://doi.org/10.1111/j.1572-0241.2001.03620.x
- Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 2004;28:365-373. https://doi.org/10.1097/00000478-200403000-00009
- Kim YS, Kim YH, Kim JS, et al. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol 2012;46:51-56. https://doi.org/10.1097/MCG.0b013e3182160c9c
- Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 2010;55:1059-1065. https://doi.org/10.1007/s10620-010-1126-4
- Knosel T, Schewe C, Petersen N, Dietel M, Petersen I. Prevalence of infectious pathogens in Crohn's disease. Pathol Res Pract 2009;205:223-230. https://doi.org/10.1016/j.prp.2008.04.018
- Nakase H, Yoshino T, Honzawa Y, Chiba T. Low prevalence of CMV infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci 2010;55:1498-1499. https://doi.org/10.1007/s10620-010-1162-0
- Pillet S, Pozzetto B, Jarlot C, Paul S, Roblin X. Management of cytomegalovirus infection in inflammatory bowel diseases. Dig Liver Dis 2012;44:541-548. https://doi.org/10.1016/j.dld.2012.03.018
- Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014;8:443-468. https://doi.org/10.1016/j.crohns.2013.12.013
- Mun JI, Shin SJ, Yu BH, et al. A case of hemophagocytic syndrome in a patient with fulminant ulcerative colitis superinfected by cytomegalovirus. Korean J Intern Med 2013;28:352-355. https://doi.org/10.3904/kjim.2013.28.3.352
- Matsumoto S, Yoshida Y. What are the factors that affect hospitalization and surgery for aggravation of ulcerative colitis? Eur J Gastroenterol Hepatol 2014;26:282-287. https://doi.org/10.1097/MEG.0000000000000028
- Park SH, Yang SK, Hong SM, et al. Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Dig Dis Sci 2013;58:3592-3599. https://doi.org/10.1007/s10620-013-2828-1
- Kim YS, Kim YH, Kim JS, et al. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver 2014;8:643-647. https://doi.org/10.5009/gnl13427
- Matsuoka K, Iwao Y, Mori T, et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007;102:331-337. https://doi.org/10.1111/j.1572-0241.2006.00989.x
- Yoshino T, Nakase H, Ueno S, et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007;13:1516-1521. https://doi.org/10.1002/ibd.20253
- do Carmo AM, Santos FM, Ortiz-Agostinho CL, et al. Cytomegalovirus infection in inflammatory bowel disease is not associated with worsening of intestinal inflammatory activity. PLoS One 2014;9:e111574. https://doi.org/10.1371/journal.pone.0111574
- McCurdy JD, Jones A, Enders FT, et al. A model for identifying cytomegalovirus in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2015;13:131-137. https://doi.org/10.1016/j.cgh.2014.05.026
- Gauss A, Rosenstiel S, Schnitzler P, et al. Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience. Eur J Gastroenterol Hepatol 2015;27:712-720. https://doi.org/10.1097/MEG.0000000000000361
- Sager K, Alam S, Bond A, Chinnappan L, Probert CS. Review article: cytomegalovirus and inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:725-733. https://doi.org/10.1111/apt.13124
- Iida T, Ikeya K, Watanabe F, et al. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus. Inflamm Bowel Dis 2013;19:1156-1163. https://doi.org/10.1097/MIB.0b013e31828075ce
- Suzuki H, Kato J, Kuriyama M, Hiraoka S, Kuwaki K, Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010;16:1245-1251. https://doi.org/10.3748/wjg.v16.i10.1245
- Kim JW, Boo SJ, Ye BD, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohns Colitis 2014;8:693-701. https://doi.org/10.1016/j.crohns.2013.12.014
- Chun J, Lee C, Kwon JE, et al. Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis. Intest Res 2015;13:50-59. https://doi.org/10.5217/ir.2015.13.1.50
- Chang S, Cheon JH. A clinical significance of assessing cytomegalovirus infection status in patients with ulcerative colitis. Intest Res 2015;13:2-3. https://doi.org/10.5217/ir.2015.13.1.2
- Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006;101:2857-2865. https://doi.org/10.1111/j.1572-0241.2006.00869.x
- Beaugerie L, Cywiner-Golenzer C, Monfort L, et al. Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:423-429. https://doi.org/10.1097/00042560-199704150-00005
- McCoy MH, Post K, Sen JD, et al. qPCR increases sensitivity to detect cytomegalovirus in formalin-fixed, paraffin-embedded tissue of gastrointestinal biopsies. Hum Pathol 2014;45:48-53. https://doi.org/10.1016/j.humpath.2013.07.040
- Cotte L, Drouet E, Bissuel F, Denoyel GA, Trepo C. Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients. J Clin Microbiol 1993;31:2066-2069.
- Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 2011;106:2001-2008. https://doi.org/10.1038/ajg.2011.202
- Ciccocioppo R, Racca F, Paolucci S, et al. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement. World J Gastroenterol 2015;21:1915-1926. https://doi.org/10.3748/wjg.v21.i6.1915
- Zidar N, Ferkolj I, Tepes K, et al. Diagnosing cytomegalovirus in patients with inflammatory bowel disease: by immunohistochemistry or polymerase chain reaction? Virchows Arch 2015;466:533-539. https://doi.org/10.1007/s00428-015-1741-8
- McCurdy JD, Enders FT, Jones A, et al. Detection of cytomegalovirus in patients with inflammatory bowel disease: where to biopsy and how many biopsies? Inflamm Bowel Dis 2015;21:2833-2838. https://doi.org/10.1097/MIB.0000000000000556
- de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 2002;25 Suppl 2:S1-S12.
- Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J Clin Microbiol 1993;31:2851-2856.
- Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010;105:501-523. https://doi.org/10.1038/ajg.2009.727
- Choi CH, Moon W, Kim YS, et al. Second Korean guideline for the management of ulcerative colitis. Korean J Gastroenterol 2017;69:1-28. https://doi.org/10.4166/kjg.2017.69.1.1
- Maconi G, Lombardini M, Furfaro F, Bezzio C, Zerbi P, Ardizzone S. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment. Eur J Gastroenterol Hepatol 2014;26:1146-1151. https://doi.org/10.1097/MEG.0000000000000175
- Shukla T, Singh S, Loftus EV Jr, Bruining DH, McCurdy JD. Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis. Inflamm Bowel Dis 2015;21:2718-2725. https://doi.org/10.1097/MIB.0000000000000489
- Jones A, McCurdy JD, Loftus EV Jr, et al. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus. Clin Gastroenterol Hepatol 2015;13:949-955. https://doi.org/10.1016/j.cgh.2014.09.042
- Omiya M, Matsushita M, Tanaka T, Kawamata S, Okazaki K. The absence of large ulcer predicts latent cytomegalovirus infection in ulcerative colitis with positive mucosal viral assay. Intern Med 2010;49:2277-2282. https://doi.org/10.2169/internalmedicine.49.3657
- Pillet S, Pozzetto B, Roblin X. Cytomegalovirus and ulcerative colitis: place of antiviral therapy. World J Gastroenterol 2016;22:2030-2045. https://doi.org/10.3748/wjg.v22.i6.2030
- Criscuoli V, Casa A, Orlando A, et al. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 2004;36:818-820. https://doi.org/10.1016/j.dld.2004.05.013
- Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:2137-2142. https://doi.org/10.1111/j.1572-0241.2001.03949.x
- Czock D, Scholle C, Rasche FM, Schaarschmidt D, Keller F. Pharmacokinetics of valganciclovir and ganciclovir in renal impairment. Clin Pharmacol Ther 2002;72:142-150. https://doi.org/10.1067/mcp.2002.126306
- Einsele H, Ehninger G, Steidle M, et al. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 1991;338:1170-1172. https://doi.org/10.1016/0140-6736(91)92032-W
- Ciccocioppo R. Letter: cytomegalovirus infection in inflammatory bowel disease. Aliment Pharmacol Ther 2015;42:127-129.
- Landsman MJ, Sultan M, Stevens M, Charabaty A, Mattar MC. Diagnosis and management of common gastrointestinal tract infectious diseases in ulcerative colitis and Crohn's disease patients. Inflamm Bowel Dis 2014;20:2503-2510. https://doi.org/10.1097/MIB.0000000000000140
- D'Ovidio V, Vernia P, Gentile G, et al. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol 2008;43:180-183. https://doi.org/10.1016/j.jcv.2008.06.002
- Lavagna A, Bergallo M, Daperno M, et al. Infliximab and the risk of latent viruses reactivation in active Crohn's disease. Inflamm Bowel Dis 2007;13:896-902. https://doi.org/10.1002/ibd.20131
- Pillet S, Jarlot C, Courault M, et al. Infliximab does not worsen outcomes during flare-ups associated with cytomegalovirus infection in patients with ulcerative colitis. Inflamm Bowel Dis 2015;21:1580-1586. https://doi.org/10.1097/MIB.0000000000000412
피인용 문헌
- Cytomegalovirus Enterocolitis and Cytomegalovirus Colitis Complicating Ulcerative Colitis vol.71, pp.10, 2017, https://doi.org/10.3862/jcoloproctology.71.470
- Cytotoxicity of Human Hepatic Intrasinusoidal CD56 bright Natural Killer Cells against Hepatocellular Carcinoma Cells vol.20, pp.7, 2017, https://doi.org/10.3390/ijms20071564
- Cytomegalovirus reactivation in inflammatory bowel disease: an uncommon occurrence related to corticosteroid dependence vol.32, pp.8, 2017, https://doi.org/10.1038/s41379-019-0258-0
- Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC) vol.8, pp.7, 2017, https://doi.org/10.3390/microorganisms8071078
- Ulcerative Colitis and Cytomegalovirus Infection: From A to Z vol.14, pp.8, 2017, https://doi.org/10.1093/ecco-jcc/jjaa036
- Diagnostic significance of cytomegalovirus DNA quantitation in gastrointestinal biopsies: comparison with histopathological data and blood cytomegalovirus DNA vol.33, pp.1, 2017, https://doi.org/10.1097/meg.0000000000001840
- Human Cytomegalovirus and Autoimmune Diseases: Where Are We? vol.13, pp.2, 2021, https://doi.org/10.3390/v13020260
- Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis vol.66, pp.12, 2017, https://doi.org/10.1007/s10620-020-06772-8
- Colitis due to Cytomegalovirus and Herpes Simplex Type 2 as a Complication of a First Presentation of Inflammatory Bowel Disease vol.29, pp.1, 2017, https://doi.org/10.1159/000514715